Published in J Reprod Med on December 01, 1972
The development of oxytocic drugs in the management of postpartum haemorrhage. Ulster Med J (2004) 0.77
Letter: Mid-trimester termination. Br Med J (1974) 0.75
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med (2000) 4.30
Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea. Lancet (1968) 3.78
Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol (1983) 3.53
Therapeutic abortion using prostaglandin F2alpha. Lancet (1970) 3.38
Prostaglandins in amine-peptide-secreting tumours. Lancet (1968) 2.75
Distribution of prostaglandins in human tissues. Br J Pharmacol Chemother (1967) 2.58
Appearance of prostaglandin F2-alpha in human blood during labour. Br Med J (1968) 2.44
The titanium/silicone rubber clip for female sterilization. Br J Obstet Gynaecol (1981) 2.25
Prostaglandin content of amniotic fluid during pregnancy and labour. J Obstet Gynaecol Br Commonw (1967) 2.10
In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii. J Immunol (1985) 2.00
Use of prostaglandin E2 for therapeutic abortion. Br Med J (1970) 1.97
Induction of labour with prostaglandin E2. J Obstet Gynaecol Br Commonw (1970) 1.95
Cognitive test performance in a community-based nondemented elderly sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study. Int Psychogeriatr (1996) 1.91
The effect of loperamide on prostaglandin induced diarrhoea in rat and man. Prostaglandins (1977) 1.83
Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion. Br Med J (1973) 1.68
Identification of prostaglandins in human amniotic fluid. J Obstet Gynaecol Br Commonw (1966) 1.62
Natural killer cells induced by acute and chronic toxoplasma infection. Cell Immunol (1982) 1.56
Oral administration of prostaglandins for the induction of labour. Br Med J (1971) 1.53
Antagonism of some smooth muscle actions of prostaglandins by polyphloretin phosphate. Br J Pharmacol (1970) 1.49
The significance of the changes in the continuous fetal heart rate in the first stage of labour. J Obstet Gynaecol Br Commonw (1971) 1.47
Effect of prostaglandins A 1 , A 2 , B 1 , E 2 and F 2 on forearm arterial bed and superficial hand veins in man. Clin Sci (1973) 1.47
Response of pregnant human uterus to prostaglandin-F2-alpha-induction of labour. Br Med J (1968) 1.47
Dosimetric verification of a high dose rate brachytherapy treatment planning system in homogeneous and heterogeneous media. Phys Med (2012) 1.46
Induction of labour with prostaglandin F2a. J Obstet Gynaecol Br Commonw (1969) 1.45
Effects of histamine on the human penis muscle in vitro. Eur J Pharmacol (1977) 1.39
Different regulation of the L3T4-T cell subset by B cells in different mouse strains bearing the H-2k haplotype. J Immunol (1986) 1.35
Effect of 15(R)15 methylprostaglandin E2 methyl ester on healing of gastric ulcers. Controlled endoscopic study. Lancet (1974) 1.30
Effects of oral administration of prostaglandins E 2 and F 2- on the human uterus. J Obstet Gynaecol Br Commonw (1971) 1.24
The identification of prostaglandins in human umbilical cord. Br J Pharmacol Chemother (1967) 1.22
Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J Neurosci (1996) 1.22
Second trimester abortion with single intra-amniotic injection of prostaglandins E2 or F2 alpha. Lancet (1971) 1.18
Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice. Infect Immun (1981) 1.17
The action of prostaglandins of the human isolated non-pregnant cervix. J Obstet Gynaecol Br Commonw (1970) 1.17
Vesicouterine fistula: MRI diagnosis. Eur Radiol (1999) 1.15
Protective immunity in toxoplasmosis: correlation between antibody response, brain cyst formation, T-cell activation, and survival in normal and B-cell-deficient mice bearing the H-2k haplotype. Infect Immun (1987) 1.11
Oxygen-independent killing by alveolar macrophages. J Exp Med (1986) 1.11
Detection of Toxoplasma gondii antigens by a dot-immunobinding technique. J Clin Microbiol (1985) 1.11
Toxoplasma antigen isolated by affinity chromatography with monoclonal antibody protects mice against lethal infection with Toxoplasma gondii. J Immunol (1984) 1.10
Mouth-operated mucus extractors: safe to use? Br J Obstet Gynaecol (1995) 1.09
Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration. J Pharmacol Exp Ther (1991) 1.07
The effect of orally and intravenously administered prostaglandin 16:16 dimethyl E2 methyl ester on human gastric acid secretion. Prostaglandins (1973) 1.07
Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. III. Inhibition by cytochalasins, colchicine, and vinblastine. Cell Immunol (1978) 1.06
Identification of compatible bacterial and fungal isolate and their effectiveness against plant disease. J Environ Biol (2013) 1.06
Target foil rupture scenario and provision for handling different models of medical cyclotrons used in India. J Med Phys (2009) 1.06
Termination of second trimester pregnancy with 15 methyl analogues of prostaglandins E 2 and F 2 . J Obstet Gynaecol Br Commonw (1972) 1.06
Use of prostaglandin E2 in the management of missed abortion, missed labour, and hydatidiform mole. Br Med J (1970) 1.05
Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii. J Immunol (1983) 1.03
Effect of 15 (R) 15 methyl prostaglandin E2 on the healing of gastric ulcers: a double-blind endoscopic study. Med J Aust (1976) 1.03
Parasiticidal activity of macrophages against Toxoplasma. Methods Enzymol (1986) 1.03
Effects of prostaglandins E1, E2, F1-alpha, F2-alpha on isolated human umbilical and placental blood vessels. J Obstet Gynaecol Br Commonw (1968) 1.02
Cloning of cDNAs encoding a 28 kilodalton antigen of Toxoplasma gondii. Mol Biochem Parasitol (1989) 1.01
Inhibition of human natural killer activity by lysosomotropic agents. J Immunol (1983) 1.01
Proceedings: Action of prostaglandins A2, B-1, E2 and F2 alpha on superficial hand veins of man. Br J Pharmacol (1972) 1.01
Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol (1989) 1.00
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest (1994) 1.00
The nature of the prostaglandin-blocking activity of polyphloretin phosphate. J Pharmacol Exp Ther (1971) 0.99
Cardiovascular and other effects of prostaglandins E 2 and F 2 in man. Cardiovasc Res (1971) 0.97
Office termination of pregnancy by "menstrual aspiration". Am J Obstet Gynecol (1979) 0.96
Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. J Med Chem (1997) 0.95
Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients. Prostaglandins (1975) 0.95
Monoclonal antibodies to stages of Trypanosoma cruzi: characterization and use for antigen detection. Infect Immun (1982) 0.95
Distribution of prostaglandins E1,E2, F1-alpha and F2-alpha in some animal tissues. J Pharm Pharmacol (1968) 0.95
Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides (1997) 0.95
Abortifacient action of orally administered 16,16 dimethyl prostaglandin E2 and its methyl ester. Prostaglandins (1974) 0.94
Enhancement of human natural killer cell activity by subcellular components of Toxoplasma gondii. Cell Immunol (1984) 0.93
Posterior uterine rupture causing fetal expulsion into the abdominal cavity: a rare case of neonatal survival. Case Rep Obstet Gynecol (2011) 0.93
Traditional concepts of mental disorder among Indian psychiatric patients: preliminary report of work in progress. Soc Sci Med (1986) 0.93
Long term response stability of a well-type ionization chamber used in calibration of high dose rate brachytherapy sources. J Med Phys (2010) 0.93
Inhibition of human gastric secretion by prostaglandin. Br J Surg (1973) 0.93
A smooth muscle contracting substance in extracts of human umbilical cord. Nature (1966) 0.93
Effect of prostaglandin 15 (R) 15 methyl-E2-methyl ester on the gastric mucosa in patients with peptic ulceration--an endoscopic and histological study. Prostaglandins (1974) 0.92
The use of prostaglandin E 2 for therapeutic abortion. J Obstet Gynaecol Br Commonw (1972) 0.90
The role of prostaglandins in human parturition. Proc R Soc Med (1971) 0.90
Vasoactive substances in Kaposi's sarcoma. Cancer (1971) 0.90
Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res (1981) 0.89
Prevention of reflex natriuresis after acute unilateral nephrectomy by melanocortin receptor antagonists. Am J Physiol (1998) 0.89
Enhancement of mouse natural killer cell activity by thyroxine. Cell Immunol (1982) 0.89
Therapeutic abortion and induction of labour by the intravaginal administration of prostaglandins E 2 and F 2- . J Obstet Gynaecol Br Commonw (1971) 0.89
Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO 41483, in primates. Prostaglandins Leukot Med (1982) 0.88
Neonatal serum bilirubin levels in spontaneous and induced labour. Br J Obstet Gynaecol (1978) 0.88
Cross-cultural differences in simple taste preferences. Science (1975) 0.88
Effects of lysosomotropic amines on human polymorphonuclear leucocyte function. Immunology (1984) 0.88
A comparison of Lamicel and prostaglandin E2 vaginal gel for cervical ripening before induction of labor. Am J Obstet Gynecol (1985) 0.88
Design, synthesis, and conformation of superpotent and prolonged acting melanotropins. Ann N Y Acad Sci (1993) 0.88
The effect of prostaglandin E2 on the cardiovascular response to angiotensin II in pregnant rabbits. Prostaglandins (1977) 0.88
Effects of some naturally occurring prostaglandins and synthetic analogues on gastric secretion and ulcer healing in man. Adv Prostaglandin Thromboxane Res (1976) 0.87
Polyphloretin phosphate - a selective antagonist for prostaglandins F1 alpha and F2 alpha. Life Sci (1970) 0.87
A dosimetry method in the transverse plane of HDR Ir-192 brachytherapy source using gafchromic EBT2 film. Phys Med (2011) 0.87
Melanocortin receptors: identification and characterization by melanotropic peptide agonists and antagonists. Pigment Cell Res (1996) 0.86
The effects of prostaglandins E 2 and F 2 alpha administered by different routes on uterine activity and the cardiovascular system in pregnant and non-pregnant women. J Obstet Gynaecol Br Commonw (1971) 0.86
Antigen-specific stimulation of T cell extracellular acidification by MHC class II-peptide complexes. J Immunol (1992) 0.86
The effect of orally administered prostaglandins A1, A2 and 15 EPI-A2 on human gastric acid secretion. Prostaglandins (1973) 0.86